Resultados de la búsqueda 491-500 of 9436 for Low-Dose Naltrexone
The most common adverse event after CAR-T therapy is lower than normal blood cells (cytopenia) and up to one third of patients experience cytopenia that last ...
Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as ...
The purpose of this study is to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy ...
... Small Lymphocytic Lymphoma Patients. Jacksonville ... small lymphocytic lymphoma. ... The purpose of this study is to characterize the safety, dose limiting ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
... dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in ... dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...
Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative Rhabdomyosarcoma ... Dose Expansion Phase (Part B) of ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
... dose (MAD) and recommended phase 2 dose (RP2D) for future study after ... Given that this is a small pilot study to generate preliminary data, there ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?